Summary

Metabolic dysfunction-associated steatotic liver disease (MASLD) – previously known as non-alcoholic fatty liver disease – affects around 30 percent of the global population and, as the name suggests, is characterized by fatty deposits building up in the liver. While this doesn't immediately cause damage or illness, it can eventually lead to severe consequences: fibrosis (liver scarring), cirrhosis (more severe scarring, and ultimately liver failure), cardiovascular disease, kidney dysfunction, and more.

AI summaries can be wrong sometimes—always verify important details using the source article.